Is It Time To Reconsider Thermo Fisher Scientific (TMO) After Its Recent Share Price Slide?

Insilico MedicineInsilico Medicine Showcases AI-Driven Inhaled Therapy for Pulmonary Fibrosis at ATS Summit - TipRanks

Samsung BiologicsCDMOs turn to pharma facility acquisitions amid manufacturing realignment: GlobalData - megaproject.com

Thermo FisherIs It Time To Reconsider Thermo Fisher Scientific (TMO) After Its Recent Share Price Slide? - simplywall.st

AmgenAmgen Inc stock (US0311621009): lungs cancer setback meets steady biotech cash flow - AD HOC NEWS

IlluminaIllumina Inc stock (US4523271090): gene sequencing player in focus after latest earnings and divesti - AD HOC NEWS

Merck & Co.Merck & Co., Inc. stock (US58933Y1055): Keytruda momentum and fresh earnings keep big pharma in focu - AD HOC NEWS

Charles RiverCharles River Labs stock (US14149Y1082): 4.45% slide puts support zone back in focus - AD HOC NEWS

10x Genomics NewsThe Bull Case For 10x Genomics (TXG) Could Change Following Mixed Q1 Results And Reaffirmed Guidance - simplywall.st

QiagenQiagen N.V. stock (NL0012169213): Q1 2026 earnings and outlook keep diagnostics specialist in focus - AD HOC NEWS

Intuitive SurgicalIntuitive Surgical stock (US46120E6023): earnings momentum and robotic surgery demand in focus - AD HOC NEWS

CellThe temporal architecture of the seminiferous epithelial cycle revealed by spatial transcriptomics

CellCell-autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysis